FDA одобрило первый ингибитор фактора свертывания XIа для профилактики повторного инсульта

nplus1.ru · world
Full story

The FDA has approved the first inhibitor of coagulation factor XIa, a drug class targeted at preventing recurrent strokes. The approval covers use in prophylaxis against a repeat stroke. The source did not name the product or its manufacturer.

FDA одобрило первый ингибитор фактора свертывания XIа для профилактики повторного инсульта

Read full article → Compare